Virginia Cancer Specialists, PC, Arlington
Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care, Blacksburg
Virginia Cancer Specialists, PC, Fairfax
a 12 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07222800

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

NEXT Oncology, Fairfax

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT05482893

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

Virginia Cancer Specialists - Fairfax /ID# 271351, Fairfax

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT06820463

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

Oncology and Hematology Associates of Southwest Virginia (BRCC) ( Site 0295), Roanoke

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06428409

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

Virginia Cancer Specialists, Arlington
Richmond VA Medical Center, Richmond
VCU Massey Comprehensive Cancer Center, Richmond

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06750094

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

Virginia Cancer Specialists, Arlington
Inova Schar Cancer Institute Dept of Fairfax Hospital, Fairfax
Richmond VA Medical Center, Richmond
a 1 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06662786

Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

University of Virginia Cancer Center, Charlottesville
VCU Massey Comprehensive Cancer Center, Richmond

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT06102902

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Local Institution - 0278, Fairfax
Virginia Oncology Associates, Norfolk

Prebieha náborFáza 2/3

Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT07221357

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Virginia Cancer Specialists, Fairfax

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06445062

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

NEXT Oncology Virginia, Fairfax

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06128551

A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer

NEXT Virginia, Faifax

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT07693751

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Next Oncology Virginia Cancer Specialist, Fairfax

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT07629960

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

NEXT - Virginia, Fairfax

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT07349537

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

NEXT Virginia, Fairfax

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT05786924

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

University of Virginia Medical Center, Charlottesville
Mary Washington Healthcare, Fredericksburg
Hematology Oncology Associates of Fredericksburg Admin, Fredericksburg
a 1 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT07284849

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

NEXT Oncology, Fairfax

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT06440005

A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

Virginia Oncology Associates, Newport News
Blue Ridge Cancer Care - 300202915, Roanoke

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07549412

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Clinical Study Site, Charlottesville
Clinical Study Site, Fairfax

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT07228832

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

Inova Schar Cancer, Fairfax

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 9. 2026 · NCT06992258

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

NEXT Virginia, Fairfax

Prebieha náborFáza 1

Vek 18 až 99 · Všetky pohlavia · Aktualizované 1. 9. 2026 · NCT06983743

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

NEXT Virginia, Fairfax

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 27. 8. 2026 · NCT07227168

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

NEXT Oncology, Fairfax

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 26. 8. 2026 · NCT07321106

Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer

Virginia Cancer Institute (VCI), Richmond
Virginia Commonwealth University, Richmond

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 8. 2026 · NCT06728072

FOG-001 in Locally Advanced or Metastatic Solid Tumors

University of Virginia, Charlottesville

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 8. 2026 · NCT05919264

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

NEXT Virginia, Fairfax

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 8. 2026 · NCT07066657

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Clinical Trial Site, Fairfax

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 6. 8. 2026 · NCT07749586

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Virginia Cancer Specialists, Fairfax

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 8. 2026 · NCT06330064

Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.